However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 16.43%, which has investors questioning if this is right ...

BEIJING -- British pharmaceutical giant AstraZeneca signed a landmark $2.5-billion agreement on Friday to invest in Beijing ...

Non-communicable diseases are costing the EU billions of euros annually. Increasing investment in detection, diagnosis, and ...

Key Takeaways Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for ...

The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...

Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old ...

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

AstraZeneca has tapped Korea's Alteogen to develop subcutaneous cancer drugs. Taiho Pharmaceutical is paying $400 million to ...

Fosamax further defines the obligation of drug manufacturers to present clear, unambiguous, and accurate information to the ...

Telix Pharmaceuticals' said its new drug application in the U.S. for an imaging agent received regulatory approval. The Melbrourne, Australia-based biopharmaceutical company said Friday that the Food ...